BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2014
View Archived Issues
Researchers present phase III clinical data for ZS-9 as treatment of hyperkalemia
Read More
Promising phase IIb results presented from the TIME trial evaluating TG-4010 in NSCLC
Read More
AB Science selects SYK kinase inhibitor AB-8779 for full preclinical development
Read More
Pfizer initiates phase II trial of PF-05089771 in painful diabetic peripheral neuropathy
Read More
Novel CDK4 and/or CDK6 inhibitors disclosed by Jiangsu Hengrui Medicine
Read More
Roche divulges novel RSV fusion protein inhibitors
Read More
Nerviano Medical Sciences synthesizes novel Ret inhibitors
Read More
Curadev Pharma discloses new IDO and/or TDO regulators
Read More
Fudan University presents novel hedgehog signaling inhibitors
Read More
Calzada changes name to PolyNovo
Read More
E.U. regulatory authorities investigate adverse events in patients who received Fluad
Read More
Icosabutate shows promise as lipid-lowering agent in animal studies and early clinical trials
Read More
Karyopharm confirms additional orphan designations for selinexor in the E.U.
Read More
Ixazomib granted FDA breakthrough therapy designation in systemic light-chain amyloidosis
Read More
Necuparanib receives FDA fast track designation for metastatic pancreatic cancer
Read More
Novartis prepares for Japanese launch of Stalevo tablets
Read More
GlaxoSmithKline presents preclinical data for the anti-HER3 antibody GSK-2849330
Read More
FDA grants fast track status to palovarotene for fibrodysplasia ossificans progressiva
Read More
FDA lifts clinical hold on FX-006 for osteoarthritis pain
Read More
Cabozantinib misses pain endpoint in COMET-2 mCRPC trial
Read More
Compound inhibiting SSAO may improve Parkinson's disease
Read More
FDA approves Priftin for latent tuberculosis infection
Read More
European marketing authorization for Xtandi extended to chemotherapy-naive prostate cancer
Read More
Baxter files BLA for BAX-855 for hemophilia A
Read More
EMA grants ALS candidate TW-001 orphan drug designation
Read More
